Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 8/20 | 0.65 |
| ▸ | BCHE | P06276 | 3/20 | 0.65 |
| ▸ | TGM2 | P21980 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.57 |
| ▸ | ALDH2 | P05091 | 3/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | CDC25A | P30304 | 1/20 | 0.55 |
| ▸ | PARK7 | Q99497 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12930202 | 0.89 | CES1 (0.65) | CES1BCHETGM2ALDH1A1AGTR1 | |
| SCHEMBL4625229 | 0.86 | CES1 (0.61) | CES1BCHETGM2ALDH1A1AGTR1 | |
| SCHEMBL10679097 | 0.83 | CES1 (0.57) | CES1BCHETGM2ALDH1A1AGTR1 | |
| SCHEMBL12930273 | 0.83 | CES1 (0.61) | CES1BCHETGM2ALDH1A1AGTR1 | |
| SCHEMBL8088024 | 0.82 | CES1 (0.56) | CES1BCHETGM2ALDH1A1AGTR1 | |
| SCHEMBL29649695 | 0.79 | CES1 (0.71) | CES1BCHETGM2ALDH1A1ALDH3A1 | |
| SCHEMBL5114051 | 0.79 | CES1 (0.71) | CES1BCHETGM2ALDH1A1ALDH3A1 | |
| SCHEMBL571882 | 0.79 | CES1 (0.71) | CES1BCHETGM2ALDH1A1ALDH3A1 | |
| SCHEMBL578329 | 0.79 | CES1 (0.71) | CES1BCHETGM2ALDH1A1AGTR1 | |
| SCHEMBL7612012 | 0.79 | CES1 (0.56) | CES1BCHETGM2ALDH1A1AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11715844-B2 | Isatin derivative redoxmer for electrochemical device | UCHICAGO ARGONNE, LLC (US) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11715844-B2 | Isatin derivative redoxmer for electrochemical device | SQOR, SLC39A14, NDUFS5 | CES1 4335/4885BCHE 622/4885TGM2 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.